BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 3, 2017
View Archived Issues
AX-024 is a first-in-class inhibitor of TCR with activity in models of autoimmune diseases
Read More
Pfizer patents PDE4 inhibitors
Read More
Almirall discloses PI3K inhibitors
Read More
Lilly describes MetAP2 inhibitors
Read More
X4 initiates phase II/III trial of X4P-001 in patients with WHIM syndrome
Read More
Bayer Pharma reports development of anticancer agents
Read More
Australian scientists present KAT6A inhibitors
Read More
In vitro and in vivo data for the novel selective TYK2 inhibitor, NDI-031301
Read More
H3B-8800 demonstrates efficacy in spliceosome-mutant myeloid malignancies
Read More
Phase I results for INCB-039110 in acute graft-versus-host disease
Read More
University Hospital of Tubingen's therapy for CNGA3-linked achromatopsia designated E.U. orphan drug
Read More
European orphan drug designation for cabiralizumab for tenosynovial giant cell tumors
Read More
Abbott to close the acquisition of St. Jude Medical
Read More
Phase II study of trastuzumab emtansine in HER2-positive UBC or metastatic pancreas/cholangio cancer
Read More
Prima BioMed announces new LAG-3 agonist antibody
Read More
Phase III efficacy and safety study of EndoTAG-1 begins
Read More
Roche begins enrollment in phase I study of GDC-0077
Read More
Roche commences phase II trial of RO-7123520 in moderate to severely active rheumatoid arthritis
Read More
European orphan drug designation awarded to ivosidenib for AML
Read More
Tiziana Life Sciences in-licenses NI-1201 from Novimmune
Read More
Saniona reports topline data from phase IIa study of Tesomet in type 2 diabetes
Read More
Scancell announces final clinical study report on phase I/II trial of SCIB-1 in melanoma
Read More
